Sort
23,748 grants matching “melanoma”
IDENTIFICATION OF MELANOMA PREDISPOSITION LOCI
$490,073Lisa A. Cannon Albright · University Of Utah · R01 · FY2007 · CA
The identification of genetic determinants of melanoma recurrence
$490,060Tomas Kirchhoff · New York University School Of Medicine · R01 · FY2016 · CA
Role of Formylpeptide Receptors in Host Defense
$489,899Ji Ming Wang · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Tumor-specific CD8+ Tc9 cells activate host CD4+ T cells to control antigen-lost tumors
$489,857Qing Yi · Methodist Hospital Research Institute · R01 · FY2025 · CA
Tumor-specific CD8+ Tc9 cells activate host CD4+ T cells to control antigen-lost tumors
$489,857Qing Yi · Methodist Hospital Research Institute · R01 · FY2024 · CA
A Convergent Node in Melanoma to Block Multiple Oncogenic Pathways Simultaneously
$489,697Lawrence Kwong · University Of Tx Md Anderson Can Ctr · R01 · FY2024 · CA
Project 2:Nanoparticle-based Immune Modulators in Cancer Therapy & Vaccines
$489,587Jenny P.y. Ting · Univ Of North Carolina Chapel Hill · U54 · FY2017 · CA
Laser speckle flowgraphy as early indicator of microvasculopathy in radiation-induced vision loss
$489,521Isabella Maria Grumbach · University Of Iowa · R01 · FY2020 · EY
Laser speckle flowgraphy as early indicator of microvasculopathy in radiation-induced vision loss
$489,521Isabella Maria Grumbach · University Of Iowa · R01 · FY2024 · EY
Laser speckle flowgraphy as early indicator of microvasculopathy in radiation-induced vision loss
$489,521Isabella Maria Grumbach · University Of Iowa · R01 · FY2023 · EY
Eastern Cooperative Oncology Group
$489,398Fox Chase Cancer Center · U10 · FY2004 · CA
EASTERN COOPERATIVE ONCOLOGY GROUP
$489,398Fox Chase Cancer Center · U10 · FY2003 · CA
Molecular Basis of Parvoviral Target Cell Specificity
$489,388Peter Tattersall · Yale University · R01 · FY2015 · CA
Molecular Basis of Parvoviral Target Cell Specificity
$489,388Peter Tattersall · Yale University · R01 · FY2016 · CA
Salicylic acid-based small-molecule Stat3 inhibitors for anticancer therapy
$489,360James K Turkson · University Of Hawaii At Manoa · R01 · FY2012 · CA
Project 4: Translation and preclinical studies of a personalized pancreas cancer vaccine
$489,305William E Gillanders · Washington University · P50 · FY2016 · CA
Novel DGKalpha inhibitors and immunotherapy for GBM and melanoma brain metastasis
$489,274Benjamin W. Purow · University Of Virginia · R01 · FY2018 · CA
A Genetic Linkage Study of Testicular Cancer
$489,272Victoria K Cortessis · University Of Southern California · R01 · FY2008 · CA
STEM CELL-LOADED ONCOLYTIC VIRUSES FOR METASTATIC MELANOMAS
$489,165The General Hospital Corporation · · FY2015 · Department of Defense
Potentiating a systemic antitumor response by interstitial localized ablative immunotherapy to synergize with immune checkpoint therapy for metastatic pancreatic tumors
$489,114Wei R. Chen · University Of Oklahoma · R01 · FY2025 · CA
Identification of Melanoma Susceptibility Gene at 1p22
$489,053Jeffrey M. Trent · Translational Genomics Research Inst · R01 · FY2007 · CA
Defining epigenetic regulators of tumor heterogeneity and metastasis in melanoma
$488,923Eva Hernando · New York University School Of Medicine · R01 · FY2024 · CA
Molecular Interactions during Neural Crest Formation
$488,859Martin Ignacio Garcia-Castro · University Of California Riverside · R01 · FY2025 · DE
Molecular Interactions during Neural Crest Formation
$488,859Martin Ignacio Garcia-Castro · University Of California Riverside · R01 · FY2023 · DE
Molecular Interactions during Neural Crest Formation
$488,858Martin Ignacio Garcia-Castro · University Of California Riverside · R01 · FY2021 · DE